Get started
Markets US Stocks Health Technology Medical Specialties

PetVivo Holdings, Inc PETV

PETV NASDAQ
PETV
PetVivo Holdings, Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals Analysis

PETV Chart

Ideas

PETV
PETV
, 1DLong
PETV: PETV

Cup and handle pattern, currently watching for a breakout out of the handle (falling wedge). When the volume starts pumping in, this thing can rip. Testing 20 day EMA.

$PETV Support and Resistance
PETV
, 1DLong
PETV: $PETV Support and Resistance

PetVivo shares are trading higher after ThinkEquity initiated coverage on the stock with a Buy rating and a $7 price target. PetVivo Holdings, Inc., a veterinary biotech and biomedical device company, engages in the licensing and commercializing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is...

We are probably at the beginning of the initial phase of wave 3
PETV
, 15Long
PETV: We are probably at the beginning of the initial phase of wave 3

Tomorrow (10/09/2021) we could experience the confirmation of the initial phase of wave 3, since today the price could not penetrate the zone of the lows that PETV left yesterday. This is a possible signal to enter in the purchase of the fractal major: it began with the low of August 25, in September 1 completed its first wave. The key is in this morning...

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Medical Specialties
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.

Breaking news

More news